Fed. Circ. Lifts Injunction On Hanmi's Generic Nexium

Law360, Washington (October 2, 2013, 4:35 PM EDT) -- The Federal Circuit has lifted a temporary injunction barring Hanmi USA Inc. from launching its generic version of AstraZeneca’s acid reflux drug Nexium, in an appeal of a New Jersey court ruling that hindered AstraZeneca’s patent infringement claims.

The Federal Circuit vacated its prior temporary injunction in an order dated Sept. 30, allowing Hanmi’s drug, a 505(b)2 NDA esomeprazole strontium product, to be launched during the appeal of a New Jersey federal court’s claims constructions of the patents-at-issue.

“The temporary injunction is vacated,” the Federal Circuit...
To view the full article, register now.